Chelmsford, Mass.-based resuscitation device maker Zoll Medical (NSDQ:ZOLL) sealed the deal with Japan’s Asahi Kasei Corp. (TYO:3407) over the weekend.
Mergers & Acquisitions
EU clears J&J’s $21B Synthes buyout | Wall Street Beat
Johnson & Johnson‘s (NYSE:JNJ) move to ditch its DePuy trauma business mollified EuroZone anti-trust regulators enough to win their approval for its $21.3 billion buyout of Synthes Inc.
BD to deal labware biz to Corning for $730M | Wall Street Beat
Becton Dickinson & Co. (NYSE:BDX) said it agreed to sell its BD Biosciences – Discovery Labware unit to Corning Inc. (NYSE:GLW) for about $730 million in cash.
MassDevice.com +7 | The top 7 med-tech stories for the week of April 2, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
Advocacy group Consumers Union got it wrong on med-tech, report says | MassDevice.com On Call
MASSDEVICE ON CALL — Consumer groups are a frequent presence in discussions of medical device regulation, but one relative newcomer may have lost some points in its representation of how the industry operates in its regulatory environment.
Consumers Union, an advocacy arm of Consumer Reports, launched a charge for more stringent FDA oversight of the industry just over a year ago with its Safe Patient Project.
MassDevice.com +3 | The top 3 med-tech stories for April 5, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Oridion shares spike 70% on Covidien merger news
MassDevice.com +3 | The top 3 med-tech stories for April 3, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
J&J ditches DePuy trauma business ahead of Synthes merger
Updated April 3, 2012, at 1:00 p.m. with comments from Biomet.
Biomet Inc. signed a binding offer to pay $280 million in cash for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopedics‘ global trauma business.
Boston Scientific launches Pluromed’s BackStop kidney stone treatment | Wall Street Beat
Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.
Fujifilm closes $1B SonoSite deal | Wall Street Beat
Fujifilm Holdings (TSE:4901) said it closed its $54-per-share acquisition of SonoSite (NSDQ: SONO).